Drugs / Carvacrol

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT05445089 Aug → Nov 2020 COVID-19, acute respiratory distress syndrome, pneumonia Venezuelan Institute for Scientific Research Completed No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Carvacrol ClinicalTrials.gov intervention name — accepted as the source's own label NCT05445089 ↗
Known as 2-hydroxy-p-cymene ChEMBL registry synonym — accepted as the source's own label CHEMBL281202 ↗
Known as 2-p-cymenol ChEMBL registry synonym — accepted as the source's own label CHEMBL281202 ↗
Known as Antioxine ChEMBL registry synonym — accepted as the source's own label CHEMBL281202 ↗
Known as Dentol ChEMBL registry synonym — accepted as the source's own label CHEMBL281202 ↗
Known as FEMA NO. 2245 ChEMBL registry synonym — accepted as the source's own label CHEMBL281202 ↗
Known as Isopropyl-o-cresol ChEMBL registry synonym — accepted as the source's own label CHEMBL281202 ↗
Known as Isothymol ChEMBL registry synonym — accepted as the source's own label CHEMBL281202 ↗
Known as NSC-6188 ChEMBL registry synonym — accepted as the source's own label CHEMBL281202 ↗
Action Inhibit “Check the inhibition of the main protease function (Mpro) of the SARS-CoV-2 agent by stable binding of the drug/protein to control viral replication.” NCT05445089 ↗
Modality Small molecule — CHEMBL281202 ↗
Route Oral “Oral solution” NCT05445089 ↗